KAS
TWST icon

Kemnay Advisory Services’s Twist Bioscience TWST Stock Holding History

Kemnay Advisory Services’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.5K Buy
549
+59
+12% +$3.84K 0.01% 261
2026
Q1 		$23.3K Buy
+490
New +$22K ﹤0.01% 595

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Kemnay Advisory Services's TWST Position: Q2 2026 in Review

Kemnay Advisory Services increased its Twist Bioscience (TWST) stake by 12% in Q2 2026, buying an estimated $3.84K and bringing the position to 549 shares worth $56.5K. The position accounts for 0.01% of the portfolio, ranked #261.

Kemnay Advisory Services first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Kemnay Advisory Services held 549 shares of Twist Bioscience worth $56.5K as of Q2 2026.
  • Kemnay Advisory Services bought 59 Twist Bioscience shares in Q2 2026, an estimated $3.84K.
  • Twist Bioscience made up 0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #261 holding.
  • Kemnay Advisory Services first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.